Nomura Asset Management

Nomura Asset Management Portfolio holdings

AUM $36.5B
1-Year Return 24.64%
This Quarter Return
+9.37%
1 Year Return
+24.64%
3 Year Return
+107.53%
5 Year Return
+178.5%
10 Year Return
+465.21%
AUM
$21.7B
AUM Growth
+$2.68B
Cap. Flow
+$1.08B
Cap. Flow %
4.99%
Top 10 Hldgs %
23.78%
Holding
1,832
New
29
Increased
566
Reduced
304
Closed
22

Sector Composition

1 Technology 29.78%
2 Healthcare 13.52%
3 Financials 10.87%
4 Consumer Discretionary 8.81%
5 Industrials 8.27%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ADPT icon
1701
Adaptive Biotechnologies
ADPT
$1.96B
0
AEG icon
1702
Aegon
AEG
$11.9B
0
AEM icon
1703
Agnico Eagle Mines
AEM
$76.4B
0
AKRO icon
1704
Akero Therapeutics
AKRO
$3.6B
0
ALC icon
1705
Alcon
ALC
$39.7B
0
ALKS icon
1706
Alkermes
ALKS
$4.97B
0
AMLX icon
1707
Amylyx Pharmaceuticals
AMLX
$873M
0
ANNX icon
1708
Annexon
ANNX
$241M
0
APLS icon
1709
Apellis Pharmaceuticals
APLS
$3.53B
0
APP icon
1710
Applovin
APP
$163B
0
ARQT icon
1711
Arcutis Biotherapeutics
ARQT
$2.04B
0
ARVN icon
1712
Arvinas
ARVN
$597M
0
ASR icon
1713
Grupo Aeroportuario del Sureste
ASR
$10.2B
0
ATEC icon
1714
Alphatec Holdings
ATEC
$2.46B
0
ATS icon
1715
ATS Corp
ATS
$2.67B
0
AWR icon
1716
American States Water
AWR
$2.87B
0
AXSM icon
1717
Axsome Therapeutics
AXSM
$6.2B
0
BABA icon
1718
Alibaba
BABA
$321B
0
BAM icon
1719
Brookfield Asset Management
BAM
$93.8B
0
BBD icon
1720
Banco Bradesco
BBD
$33.7B
0
BBIO icon
1721
BridgeBio Pharma
BBIO
$10.2B
0
BBVA icon
1722
Banco Bilbao Vizcaya Argentaria
BBVA
$105B
0
BCE icon
1723
BCE
BCE
$23B
0
BCRX icon
1724
BioCryst Pharmaceuticals
BCRX
$1.73B
0
BCS icon
1725
Barclays
BCS
$69.2B
0